Table of Contents
What is abacavir lamivudine used for?
Abacavir and lamivudine combination is used together with other medicines to treat human immunodeficiency virus (HIV) infection. HIV is the virus that causes acquired immune deficiency syndrome (AIDS).
What is the use of Dolutegravir lamivudine?
Dolutegravir and lamivudine is a combination antiviral medicine used to treat human immunodeficiency virus (HIV), the virus that can cause the acquired immunodeficiency syndrome (AIDS).
What are the side effects of Dolutegravir lamivudine?
Check with your doctor right away if you have the following symptoms: a severe rash or rash with fever, blistering or peeling skin, diarrhea, nausea, vomiting, joint or muscle pain, sores in the mouth, swelling of the face, trouble breathing, unusual tiredness or weakness, or yellow eyes or skin.
What does dolutegravir do to the body?
Dolutegravir is in a class of medications called HIV integrase inhibitors. It works by decreasing the amount of HIV in your blood and increasing the number of immune cells that help fight infections in your body.
Is abacavir safe during pregnancy?
Abacavir / lamivudine Pregnancy Warnings Animal studies with abacavir (high-dose) have revealed evidence of embryonic and fetal toxicity, including developmental toxicity, fetal anasarca, skeletal malformations, and increased incidence of stillbirth.
Is lamivudine the same as abacavir?
Abacavir and lamivudine both belong to a class of drugs known as nucleoside reverse transcriptase inhibitors (NRTIs). Abacavir/lamivudine is not a cure for HIV infection. To decrease your risk of spreading HIV disease to others, continue to take all HIV medications exactly as prescribed by your doctor.
How long does dolutegravir stay in the body?
At 96 hours after the last dose, dolutegravir remained detectable in all participants and above the IC90 in 4 of 17. At 72 hours elvitegravir remained detectable in 9 of 17 participants, all below the IC90.
When should dolutegravir be avoided?
It is not recommended to take dolutegravir at the time of becoming pregnant or during the first 12 weeks of pregnancy. Dolutegravir is not recommended for women who might become pregnant and should be used with effective contraception.